This article is more than 5 years old. Information may no longer be current.

Laser procedure shows promising early results for presbyopia correction

Issue: May 10, 2011

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO — Three-month study outcomes for a newer excimer-based procedure show its potential efficacy in treating presbyopia, according to a presenter here.

SupraCor (Technolas Perfect Vision) is a laser procedure for refractive and cataract surgery that uses a presbyopic algorithm to treat myopic, hyperopic, emmetropic and post-LASIK eyes, Roberto Zaldivar, MD, an OSN Refractive Surgery Board Member, said at the American Society of Cataract and Refractive Surgery meeting.

"SupraCor might be a good option for patients between 40 and 55 years old with presbyopia," he said.

Dr. Zaldivar and colleagues used the blended vision procedure to treat 12 eyes with myopia or myopic astigmatism. At 3 months postoperative, mean uncorrected visual acuity was 20/30 and mean near visual acuity was 20/16. In bilateral vision, uncorrected visual acuity was 20/20 and near visual acuity was 20/16.

"SupraCor can treat presbyopia combined with myopia and astigmatism," Dr. Zaldivar said. "Ongoing new studies will be necessary to confirm this data."

• Disclosure: Dr. Zaldivar received a non-restricted grant from Technolas Perfect Vision.

These are early results for a new method of treating presbyopia on the cornea with an excimer laser. The results look promising, and patient satisfaction in the study was high. The number of studies using this technology and the interest displayed during this particular session at the American Society of Cataract and Refractive Surgery meeting reflect the demand from patients for an effective presbyopia treatment and the desire for surgeons to provide a safe and effective treatment that offers a good range of focus without sacrificing quality of vision. I think it will be exciting to see how this technology evolves as the demand for presbyopia correction increases with the aging world population.

– Y. Ralph Chu, MD
Medical Director, Chu Vision Institute
Disclosure: Dr. Chu has no relevant financial disclosures.